Sierra Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Sierra Capital’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$531K	Hold	12,636	–	–	0.05%	167
2026 Q1	$334K	Hold	12,636	–	–	0.04%	189
2025 Q4	$366K	Hold	12,636	–	–	0.04%	172
2025 Q3	$351K	Hold	12,636	–	–	0.04%	185
2025 Q2	$308K	Hold	12,636	–	–	0.04%	187
2025 Q1	$262K	Hold	12,636	–	–	0.03%	178
2024 Q4	$298K	Sell	12,636 -6,035	-32%	-$149K	0.04%	170
2024 Q3	$478K	Hold	18,671	–	–	0.06%	162
2024 Q2	$438K	Hold	18,671	–	–	0.06%	154
2024 Q1	$537K	Hold	18,671	–	–	0.07%	148
2023 Q4	$613K	Hold	18,671	–	–	0.09%	133
2023 Q3	$520K	Hold	18,671	–	–	0.08%	136
2023 Q2	$636K	Sell	18,671 -3,680	-16%	-$116K	0.1%	127
2023 Q1	$672K	Sell	22,351 -57,875	-72%	-$1.79M	0.11%	121
2022 Q4	$2.27M	Buy	80,226 +14,669	+22%	+$466K	0.39%	59
2022 Q3	$2.15M	Hold	65,557	–	–	0.4%	58
2022 Q2	$2.06M	Buy	65,557 +35,499	+118%	+$1.24M	0.37%	61
2022 Q1	$1.38M	Hold	30,058	–	–	0.22%	96
2021 Q4	$1.84M	Hold	30,058	–	–	0.27%	82
2021 Q3	$2.26M	Hold	30,058	–	–	0.38%	67
2021 Q2	$2.78M	Buy	+30,058	New	+$2.56M	0.52%	55

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Sierra Capital's ARKG Position: Q2 2026 in Review

Sierra Capital held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 12,636 shares worth $531K. The position accounts for 0.05% of the portfolio, ranked #167.

Sierra Capital first reported a position in ARKG in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.78M in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Sierra Capital held 12,636 shares of ARK Genomic Revolution ETF worth $531K as of Q2 2026.
Sierra Capital left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up 0.05% of Sierra Capital's portfolio in Q2 2026, its #167 holding.
Sierra Capital first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 21 quarters since.
Sierra Capital's ARK Genomic Revolution ETF position peaked at $2.78M in Q2 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Sierra Capital's 13F filing for Q2 2026, filed 14 Aug 2026.